ProShare Advisors’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
11,856
-4,675
| -28% | -$47.5K | ﹤0.01% | 1841 |
|
|
2025
Q1 | $92.2K | Sell |
16,531
-4,152
| -20% | -$23.2K | ﹤0.01% | 1850 |
|
|
2024
Q4 | $167K | Buy |
20,683
+4,881
| +31% | +$39.4K | ﹤0.01% | 1940 |
|
|
2024
Q3 | $162K | Buy |
+15,802
| New | +$162K | ﹤0.01% | 1783 |
|
|
2024
Q2 | – | Sell |
-11,733
| Closed | -$161K | – | 1957 |
|
|
2024
Q1 | $161K | Buy |
+11,733
| New | +$161K | ﹤0.01% | 1725 |
|
|
2022
Q1 | – | Sell |
-12,447
| Closed | -$184K | – | 2273 |
|
|
2021
Q4 | $184K | Sell |
12,447
-2
| -0% | -$30 | ﹤0.01% | 2065 |
|
|
2021
Q3 | $260K | Sell |
12,449
-1,869
| -13% | -$39K | ﹤0.01% | 1647 |
|
|
2021
Q2 | $253K | Buy |
14,318
+3,187
| +29% | +$56.3K | ﹤0.01% | 2000 |
|
|
2021
Q1 | $273K | Buy |
11,131
+562
| +5% | +$13.8K | ﹤0.01% | 1858 |
|
|
2020
Q4 | $358K | Buy |
+10,569
| New | +$358K | ﹤0.01% | 1494 |
|